UroGen Pharma Ltd. (URGN)
NASDAQ·Healthcare·Biotechnology
$25.40
+2.77%
Mkt Cap $1.68B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$56.60
Range $44.00 – $75.00
Implied Upside
+122.8%
Consensus $56.60 vs current $25.40
NASDAQ·Healthcare·Biotechnology
$25.40
+2.77%
Mkt Cap $1.68B
Buy
9
Hold
0
Sell
0
Price Target (18 analysts)
$56.60
Range $44.00 – $75.00
+122.8%
Consensus $56.60 vs current $25.40